Assaf Halevy, CEO and founder of 2bPrecise, says genomic information can be injected into the workflow to manage the treatment of the patient. Global Precision Medicine By HIMSS TV | May 3, 2021 | 9:40 AM Topic: Telehealth, Precision Medicine
